Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Securities Code: 4368
June 7, 2023
To Our Shareholders:
Shinichi Sugita, Representative Director and President
FUSO CHEMICAL CO., LTD.
3-10, Koraibashi 4-chome,Chuo-ku, Osaka
Notice of the 66th Annual General Meeting of Shareholders
We are pleased to announce the 66th Annual General Meeting of Shareholders of the Company, which will be held as described below.
When convening this general meeting of shareholders, the Company takes measures for providing information that constitutes the content of Reference Documents for the General Meeting of Shareholders, etc. (items for which measures for providing information in electronic format are to be taken) in electronic format, and posts this information as "Notice of the 66th Annual General Meeting of Shareholders" on each of the following websites. Please access either of those websites by using the internet address shown below to review the information.
The Company's website: https://fusokk.co.jp (in Japanese)
Website for posted informational materials for the general meeting of shareholders: https://d.sokai.jp/4368/teiji/ (in Japanese)
In addition to posting items for which measures for providing information in electronic format are to be taken on each of the websites above, the Company also posts this information on the website of Tokyo Stock Exchange, Inc. (TSE). To access this information from the latter website, access the TSE website (Listed Company Search) by using the internet address shown below, enter "FUSO CHEMICAL" in the issue name (company name) or "4368" in the securities code, and click "Search," and then click "Basic information" and select "Documents for public inspection/PR information." Under "Filed information available for public inspection," click "Click here for access" under "[Notice of General Shareholders Meeting /Informational Materials for a General Shareholders Meeting]."
TSE website (Listed Company Search): https://www2.jpx.co.jp/tseHpFront/JJK010010Action.do?Show=Show (in Japanese)
If you are unable to attend on the day of the meeting, you may exercise your voting rights via the Internet, etc. or in writing. Please review the Reference Documents for the General Meeting of Shareholders, and exercise your voting rights by 5:45 p.m. on Thursday, June 22, 2023 (JST).
[When exercising voting rights via the Internet, etc.]
Please vote by the above stated deadline for exercising voting rights.
[When exercising voting rights in writing]
Please indicate your votes for each proposal on the enclosed voting form, and return it by the above stated deadline for exercising your votes.
- Date and time: Friday, June 23, 2023, at 10:00 a.m. (JST)
- Venue:4th Floor, Osaka Club
4-11, Imabashi 4-chome,Chuo-ku, Osaka
3. Objectives of meeting: Items to be reported:
1. Reports on the Business Report, the Consolidated Financial Statements, and the results of audit of the Consolidated Financial Statements by the Financial Auditor and Audit and Supervisory Committee for the 66th fiscal term (from April 1, 2022 to March 31, 2023)
- 1 -
2. Report on the Non-consolidated Financial Statements for the 66th fiscal term (from April 1, 2022 to March 31, 2023)
Items to be resolved:
Proposal No. 1 Appropriation of Surplus
Proposal No. 2 Election of Seven Board Directors (Excluding Board Directors Who Are Audit and Supervisory Committee Members)
Proposal No. 3 Election of One Board Director Who Is an Audit and Supervisory Committee Member
Proposal No. 4 Determination of Remuneration for Granting Restricted Shares to Board Directors (Excluding Board Directors Who Are Audit and Supervisory Committee Members and External Board Directors)
- If you are attending on the day of the meeting, you are kindly requested to submit the enclosed voting form to the reception staff.
- Of the items for which measures for providing information in electronic format are to be taken, the System to Ensure the Proper Operation of Business and the Status of Operation of the System in the Business Report, the Consolidated Statement of Changes in Equity and Notes to Consolidated Financial Statements of the Consolidated Financial Statements, together with Non-consolidated Statement of Changes in Equity and Notes to Non-consolidated Financial Statements of the Non-consolidated Financial Statements are not included in the paper-based documents to be delivered to shareholders who have made a request for delivery of paper-based documents pursuant to the provisions of laws and regulations and Article 15 of the Company's Articles of Incorporation. Accordingly, the documents that are delivered to shareholders who have made a request for delivery of paper-based documents are part of the documents included in the scope of audits by the Audit and Supervisory Committee Members and the Financial Auditor when they create their respective audit reports.
- If revisions to the items for which measures for providing information in electronic format are to be taken arise, a notice of the revisions and the details of the items before and after the revisions will be posted on the website for measures for providing information in electronic format on the previous page.
- As the timing of the cessation of COVID-19 is uncertain, shareholders attending the meeting in person are kindly requested to check the status of infection as well as their physical condition on the day of the meeting. Particularly for shareholders who are elderly, pregnant, or with underlying medical conditions, please make a careful decision.
- Souvenirs will not be handed out to shareholders attending on the day of the meeting. Your understanding would be much appreciated.
- 2 -
Reference Documents for the General Meeting of Shareholders
Proposal No. 1 Appropriation of Surplus
The Company appropriates surplus based on a basic policy of long-term stable return to shareholders taking into consideration strengthening the corporate structure and future business development.
The Company proposes to pay a year-end dividend for the 66th fiscal term of ¥33 per share as follows based on the business performance for the fiscal year under review.
Total dividends per share for the fiscal year including the interim dividend (¥30 per share) will be ¥63 per share.
Matters regarding year-end dividends
- Type of dividend property To be paid in cash.
- Matters regarding the allocation of dividend property and the total amount thereof The Company proposes to pay a dividend of ¥33 per common share of the Company. In this event, the total dividends will be ¥1,163,036,622.
- Effective date of dividends of surplus June 26, 2023
- 3 -
Proposal No. 2 | Election of Seven Board Directors (Excluding Board Directors Who Are Audit and |
Supervisory Committee Members) |
The terms of office of all current seven Board Directors (excluding Board Directors who are Audit and Supervisory
Committee Members; the same shall apply throughout this proposal) will expire at the conclusion of the meeting.
Therefore, the Company proposes the election of seven Board Directors.
The Audit and Supervisory Committee of the Company believes that all candidates for Board Directors are qualified for this proposal.
The candidates for Board Directors are as follows:
Candidate | Name | Career summary, position and responsibility in the Company, | Number of the | |
Company's shares | ||||
No. | (Date of birth) | and significant concurrent positions outside the Company | ||
owned | ||||
June 1988 | External Board Director of the Company | |||
Mar. 1999 | Executive Officer of Teikoku Seiyaku Co., Ltd. | |||
Mar. 2011 | President & CEO (current position) | |||
June 2017 | Representative Director & Chairman of the | |||
Misako Fujioka | Company (current position) | |||
June 2020 | Outside Director (Audit and Supervisory | |||
(April 22, 1955) | 122,802 shares | |||
Committee Member) of Asahi Broadcasting | ||||
[Reelection] | ||||
Group Holdings Corporation (current position) | ||||
1 | [Significant concurrent positions outside the Company] | |||
President & CEO of Teikoku Seiyaku Co., Ltd. | ||||
Outside Director (Audit and Supervisory Committee Member) | ||||
of Asahi Broadcasting Group Holdings Corporation | ||||
[Reasons for nomination as candidate for Board Director] | ||||
Misako Fujioka presently holds a position as President & CEO of Teikoku Seiyaku Co., Ltd. and has abundant | ||||
knowledge and experience in the overall management of a company. Accordingly, judging that she is capable of | ||||
contributing to the development of the Company group (the "Group"), the Company continues to nominate her as | ||||
candidate for Board Director. | ||||
Apr. 1980 | Joined Fujisawa Pharmaceutical Co., Ltd. | |||
(currently Astellas Pharma Inc.) | ||||
Apr. 2005 | Joined the Company | |||
Apr. 2006 | Department Manager of Planning and | |||
Development Department of Sales | ||||
Development Division of Life Science Business | ||||
Unit | ||||
Shinichi Sugita | July 2012 | Executive Officer, Division Manager of | ||
(October 5, 1955) | Electronic Materials Division, and Site | 10,103 shares | ||
[Reelection] | Manager of Kyoto Plant | |||
2 | Feb. 2019 | Deputy Division Manager of Administration | ||
Division | ||||
June 2019 | Board Director, Division Manager of | |||
Administration Division, and in charge of | ||||
Innovation Promotion Office | ||||
June 2020 | Representative Director & President (current | |||
position) | ||||
[Reasons for nomination as candidate for Board Director] | ||||
Shinichi Sugita has experience and expertise in the life science and electronic materials businesses, as well as | ||||
knowledge which he had obtained from managerial work as a Site Manager of a plant and a Division Manager of the | ||||
Administration Division. Judging that he is capable of contributing to the Group's development by utilizing these, the | ||||
Company continues to nominate him as candidate for Board Director. |
- 4 -
Candidate | Name | Career summary, position and responsibility in the Company, | Number of the | |
Company's shares | ||||
No. | (Date of birth) | and significant concurrent positions outside the Company | ||
owned | ||||
Apr. 1990 | Joined the Company | |||
July 2005 | Department Manager of Electronic Materials | |||
Sales Development Department of Electronic | ||||
Materials Business Division | ||||
Feb. 2008 | Division Manager of Electronic Materials | |||
Haruo Masauji | Division of Electronic Materials Business Unit | |||
July 2008 | Executive Officer | |||
(March 23, 1967) | 27,152 shares | |||
July 2010 | Senior Executive Officer and General Manager | |||
[Reelection] | ||||
of Electronic Materials Business Unit (current | ||||
3 | ||||
position) | ||||
June 2011 | Board Director | |||
Apr. 2019 | Managing Director | |||
June 2020 | Senior Managing Director (current position) | |||
and in charge of Innovation Promotion Office | ||||
[Reasons for nomination as candidate for Board Director] | ||||
Haruo Masauji is assisting the president in the overall management while supporting the administration by utilizing his | ||||
experience and expertise in the electronic materials business. Accordingly, judging that he is capable of contributing to | ||||
businesses the Company is developing, the Company continues to nominate him as candidate for Board Director. | ||||
Dec. 1989 | Joined the Company | |||
Feb. 2008 | General Manager of Shanghai Branch of | |||
Qingdao Fuso Refining & Processing Co., Ltd. | ||||
Aug. 2008 | President of FUSO (THAILAND) CO., LTD. | |||
May 2011 | Division Manager of Asia Business | |||
Development Division of Life Science Business | ||||
Unit and Department Manager of Sales | ||||
Department of the Company | ||||
Takashi Tanimura | Apr. 2013 | General Manager of Life Science Business Unit | ||
(November 27, 1964) | July 2013 | Senior Executive Officer | 29,167 shares | |
[Reelection] | June 2014 | Board Director | ||
4 | Apr. 2019 | Managing Director, in charge of Life Science | ||
Business Unit, and Department Manager of | ||||
Planning and Development Office | ||||
June 2020 | Senior Managing Director (current position), in | |||
charge of Life Science Business Unit, and | ||||
Planning and Development Office | ||||
Apr. 2021 | General Manager of International Division | |||
(current position) | ||||
[Reasons for nomination as candidate for Board Director] | ||||
Takashi Tanimura is assisting the president in the overall management while supporting the administration by utilizing | ||||
his experience and expertise in the life science business. Accordingly, judging that he is capable of contributing to | ||||
businesses the Company is developing, the Company continues to nominate him as candidate for Board Director. | ||||
Apr. 1992 | Joined the Company | |||
Apr. 2010 | Department Manager of Sales Development | |||
Department of Electronic Materials Business | ||||
Motoki Sugimoto | Unit | |||
July 2015 | Executive Officer and Department Manager of | |||
(November 11, 1968) | 2,667 shares | |||
Sales Development Department of Life Science | ||||
[Reelection] | ||||
Business Unit | ||||
5 | ||||
Apr. 2019 | General Manager of Life Science Business Unit | |||
(current position) | ||||
June 2019 | Board Director (current position) | |||
[Reasons for nomination as candidate for Board Director] | ||||
Motoki Sugimoto has experience and expertise in the life science and electronic materials businesses. Judging that he is | ||||
capable of contributing to businesses the Company is developing by utilizing them through his execution of duties as | ||||
Board Director, the Company continues to nominate him as candidate for Board Director. |
- 5 -
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Fuso Chemical Co. Ltd. published this content on 07 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 June 2023 06:10:43 UTC.